RE:RE:Manipulation!Cf.....I think the shorting we see going on could have been better minimized if Matt had made a more concerted effort at being a little less predictable, but I believe his attitude was “why bother”, because he is, as he clearly stated, in talks with multiple pharma, and he, more than anyone, knows that it’s only a matter of time before a deal is reached....and as illustrated by the example that Notable showed us of Sigilon Therapeutics, the shareprice is only window dressing as compared to what the ultimate buyout price is going to be......anyway, when you think about it, who doesn’t love a nice “Donnybrook style” short squeeze......let the shorts have at it, at their own peril. :)